CELLDEX THERAPEUTICS
associated with 30 other trademarks
Vaccines, therapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of cancer, autoimmune disor...

Words that describe this trademark:

monoclonal antibodies treatment  treatment cancer  antibodies treatment  therapeutic pharmaceuticals  therapeutic vaccines  cancer  pharmaceuticals  derived  vaccines 

Serial Number:

78501454

Mark:

CELLDEX THERAPEUTICS

Status:

Renewed

Status Date:

07-19-2019

Filing Date:

Registration Number:

3641176

Registration Date:

06-16-2009

Goods and Services:

Vaccines, therapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of cancer, autoimmune disorders, infectious diseases and graft-verus-host disease

Mark Description:

The mark consists of the words "CELLDEX THERAPEUTICS" with an abstract depiction of an antibody.

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

01-24-2006

Mark Drawing Status:

Design plus Words, Letters, and/or Numbers

Abandon Date:

N/A

Business Name:

LOWENSTEIN SANDLER LLP

Correspondent Name:

Recent Trademark filings by this company